Profile
ADGM ABT BSX-PA SYK MDT BSX
Company Name Adagio Medical Holdings, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $15.37M $192.90B $175.45B $137.02B $131.98B $113.11B
Employees 0.08K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Todd Usen Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
ADGM ABT BSX-PA SYK MDT BSX
Quant Rating Score 2 2 3 3 1
Quant Rating Sell Sell Neutral Neutral Strong Sell
Trading
ADGM ABT BSX-PA SYK MDT BSX
Last Close $0.7701 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $2.67 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 $0.74 $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High -71.16 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 4.07 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
ADGM ABT BSX-PA SYK MDT BSX
1 Month Return -43.99 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return -40.53 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return -34.74 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return -42.53 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return -26.66 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return -68.44 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ADGM ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.17 % - 0.95 % 2.75 % -
Dividend Paid and Capex Coverage Ration (TTM) -14.03 % 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Growth
ADGM ABT BSX-PA SYK MDT BSX
Asset Growth 609.86 % - 11.34 % 1.89 % 12.12 %
Gross Profit Growth -65.81 % 15.39 % 10.39 % 3.58 % 16.26 %
Revenue Growth -10.33 % 5.67 % 11.16 % 3.62 % 17.61 %
Revenue 3 Year 25.77 % 1.9 % 34.71 % 10.52 % 36.16 %
Revenue 5 Year - 29.99 % 71.94 % 20.96 % 47.52 %
Revenue 10 Year - 83.13 % 148.82 % 41.05 % 104.22 %
EBIT Growth -96.36 % 12.74 % 15.72 % 14.42 % 18.25 %
Net Income Growth -40.94 % -51.32 % 8.45 % 26.82 % 16.38 %
Net Income 3 Yeari Growth Per Share -240.41 % -5.58 % 36.22 % -3.39 % 72.31 %
Net Income 5 Yeari Growth Per Share -501202.18 % 47.3 % 99.44 % 1.52 % -62.7 %
Net Income 10 Yeari Growth Per Share -501202.18 % 24.34 % 122.27 % 48.51 % 1502.13 %
Operating Income Growth -123.61 % 17.92 % 11.14 % 15.77 % 20.82 %
Operating Cash Flow Growth (CFG) -14.84 % - 18.91 % 3.79 % 37.24 %
Operating 3 Year CFG -92.62 % -100 % 90.21 % 0.13 % 77.55 %
Operating 5 Year CFG - -100 % 51.22 % 1.55 % 76.92 %
Operating 10 Year CFG - -100 % 452.85 % 22.45 % 143.61 %
EPS Growth 27.16 % -51.24 % 8.02 % 31.05 % 16.61 %
EPS Diluted Growth 27.16 % -51.31 % 8.25 % 30.8 % 16.52 %
Book Value Per Share 107.8 % -100 % 8.31 % -1.16 % 11.25 %
Share Holder 3 Year Equity Growth Per Share 134.62 % -100 % 33.52 % -4.58 % 26.58 %
Share Holder 5 Year Equity Growth Per Share 185765.4 % -100 % 68.35 % -1.29 % 48.35 %
Share Holder 10 Year Equity Growth Per Share 185765.4 % -100 % 159.56 % -23.12 % 186.31 %
Dividend Per Share Growth - 6.54 % 5 % 1.11 % -100 %
Dividend 3 Year Growth Per Share - 25.03 % 20.89 % 10.78 % -100 %
Dividend 5 Year Growth Per Share - 63.45 % 46.18 % 29.33 % -
Dividend 10 Year Growth Per Share - 140.85 % 142.84 % 128.74 % -
Debt Growth -57.64 % - 5.23 % 13.95 % 17.44 %
Free Cash Flow Growth -19.71 % - 22.83 % -0.29 % 55.31 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2025 30 Apr 2025 31 Dec 2024
Profitability
ADGM ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 746.85 % 55.51 % 65.05 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -236.42 % 7.75 % 6.53 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM -752.11 % 13.18 % 12.42 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM -314.13 % 11.56 % 8.97 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 106.51 % 77.06 % 85.26 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM 102.05 % 105.19 % 97.5 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM 47985.5 % 18.16 % 17.33 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM -100.09 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM - 4.26 6.84 6.22 5.44 7.1
Payables Turnover TTM 0.9 4.78 6.75 - 5.08 6.21
Inventory Turnover TTM 0.6 2.94 2.32 1.72 2.13 2.13
Fixed Asset Turnover TTM -5.81 % 385.33 % 451.15 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM -0.45 % 52.66 % 45.31 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM -1.43 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM -1.53 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 30.38 % 442.64 % 86.05 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM 15375.52 % 20.57 % 23.91 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 107.13 % 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM -100.09 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM -0.65 27.89 35.99 31.99 25.35 29.96
Price To Operating Cash Flows Ratio TTM -0.71 21.23 29.35 27.17 18.54 24.45
Price Cash Flow Ratio TTM -0.71 21.23 29.35 27.17 18.54 24.45
Income Statement (TTM)
ADGM ABT BSX-PA SYK MDT BSX
Revenue $0B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $-0B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio -620.07% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-0.06B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0.05B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -3.54 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
ADGM ABT BSX-PA SYK MDT BSX
Long Term Debt $0.02B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0.03B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $0.02B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0.02B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.05B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
ADGM ABT BSX-PA SYK MDT BSX
Net Income $-0.08B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $0B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0.03B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 110.83
AEMD Aethlon Medical, Inc. 2.23
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.65
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 187.6
ALUR Allurion Technologies Inc. 1.1
AMIX Autonomix Medical, Inc. Common Stock 0.3984
ANIK Anika Therapeutics, Inc. 10.46
AORT Artivion, Inc. 39.59
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.88
ARAY Accuray Incorporated 0.62
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.82
AVNS Avanos Medical, Inc. 14.59
AVR Anteris Technologies Global Corp. Common Stock 5.49
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 34.93
ETFs With Exposure to ADGM
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 340.96
VXF Vanguard Extended Market Index Fund 0.00003 217.96
VUN.TO Vanguard U.S. Total Market Index ETF 0 126.63
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0 118.21
VGRO.TO Vanguard Growth ETF Portfolio 0 44.01
VEQT.TO Vanguard All-Equity ETF Portfolio 0 55.34
VBAL.TO Vanguard Balanced ETF Portfolio 0 37.61
VCNS.TO Vanguard Conservative ETF Portfolio 0 31.94
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.22
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.82
VTSAX Vanguard Total Stock Market Index Fund 0 166.03
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00003 165.43
VITSX Vanguard Total Stock Market Index Fund 0 166.06
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00003 165.44
VTS.AX Vanguard US Total Market Shares Index ETF 0 479.23
VEMPX Vanguard Extended Market Index InstlPlus 0.00003 408.25
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 311.51
Unlock